{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:38:07Z","timestamp":1791005887580,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173900"],"award-info":[{"award-number":["82173900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR4072"],"award-info":[{"award-number":["SHDC2020CR4072"]}]},{"name":"2022 Shanghai Young Pharmaceutical Talent Ability Enhancement Project","award":["HYHZ [2023] No. 04"],"award-info":[{"award-number":["HYHZ [2023] No. 04"]}]},{"name":"the14th Five Year Plan for Strengthening the Sea of the First Affiliated Hospital of Naval Medical University","award":["GH145-38"],"award-info":[{"award-number":["GH145-38"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11096-024-01726-w","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T14:02:26Z","timestamp":1717077746000},"page":"918-925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of intra-patient variability of tacrolimus on allograft function and CD4\u2009+\u2009\/CD8\u2009+\u2009ratio in kidney transplant recipients: a retrospective single-center study"],"prefix":"10.1007","volume":"46","author":[{"given":"Xuebin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaile","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-7961","authenticated-orcid":false,"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"1726_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.34971","volume":"5","author":"S Strohmaier","year":"2022","unstructured":"Strohmaier S, Wallisch C, Kammer M, et al. Survival benefit of first single-organ deceased donor kidney transplantation compared with long-term dialysis across ages in transplant-eligible patients with kidney failure. JAMA Netw Open. 2022;5: e2234971.","journal-title":"JAMA Netw Open"},{"key":"1726_CR2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2215\/CJN.15040920","volume":"16","author":"D Wojciechowski","year":"2021","unstructured":"Wojciechowski D, Wiseman A. Long-term immunosuppression management: opportunities and uncertainties. Clin J Am Soc Nephrol. 2021;16:1264\u201371.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1726_CR3","first-page":"1093","volume":"14","author":"L Chen","year":"2021","unstructured":"Chen L, Yang Y, Wang X, et al. Wuzhi capsule dosage affects tacrolimus elimination in adult kidney transplant recipients, as determined by a population pharmacokinetics analysis. Pharmgenomics Pers Med. 2021;14:1093\u2013106.","journal-title":"Pharmgenomics Pers Med"},{"key":"1726_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","volume":"16","author":"JCA Broen","year":"2020","unstructured":"Broen JCA, van Laar JM. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat Rev Rheumatol. 2020;16:167\u201378.","journal-title":"Nat Rev Rheumatol"},{"key":"1726_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2020.100531","volume":"34","author":"R Oberbauer","year":"2020","unstructured":"Oberbauer R, Bestard O, Furian L, et al. Optimization of tacrolimus in kidney transplantation: new pharmacokinetic perspectives. Transplant Rev. 2020;34: 100531.","journal-title":"Transplant Rev"},{"key":"1726_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, van Gelder T, \u00c5sberg A, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit. 2019;41:261\u2013307.","journal-title":"Ther Drug Monit"},{"key":"1726_CR7","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/pharmaceutics14091755","volume":"14","author":"M Brunet","year":"2022","unstructured":"Brunet M, Pastor-Anglada M. Insights into the pharmacogenetics of tacrolimus pharmacokinetics and pharmacodynamics. Pharmaceutics. 2022;14:1755.","journal-title":"Pharmaceutics"},{"key":"1726_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/phar.2480","volume":"41","author":"L Schumacher","year":"2021","unstructured":"Schumacher L, Leino AD, Park JM. Tacrolimus intrapatient variability in solid organ transplantation: a multiorgan perspective. Pharmacotherapy. 2021;41:103\u201318.","journal-title":"Pharmacotherapy"},{"key":"1726_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14297","volume":"26","author":"JS Choi","year":"2022","unstructured":"Choi JS, Ko H, Kim HK, et al. Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation. Pediatr Transplant. 2022;26: e14297.","journal-title":"Pediatr Transplant"},{"key":"1726_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109028","volume":"110","author":"SP Li","year":"2022","unstructured":"Li SP, Zhang JM, Chen XJ, et al. Characteristics of changes in double positive CD4+CD8+ T cells in liver transplantation. Int Immunopharmacol. 2022;110: 109028.","journal-title":"Int Immunopharmacol"},{"key":"1726_CR11","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/cid\/ciad136","volume":"76","author":"R Ron","year":"2023","unstructured":"Ron R, Moreno E, Mart\u00ednez-Sanz J, et al. CD4\/CD8 ratio during human immunodeficiency virus treatment: Time for routine monitoring? Clin Infect Dis. 2023;76:1688\u201396.","journal-title":"Clin Infect Dis"},{"key":"1726_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trre.2015.01.002","volume":"29","author":"N Shuker","year":"2015","unstructured":"Shuker N, van Gelder T, Hesselink DA. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. Transplant Rev. 2015;29:78\u201384.","journal-title":"Transplant Rev"},{"key":"1726_CR13","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.3934\/mbe.2021287","volume":"18","author":"A Ferreira","year":"2021","unstructured":"Ferreira A, Lapa R, Vale N. A retrospective study comparing creatinine clearance estimation using different equations on a population-based cohort. Math Biosci Eng. 2021;18:5680\u201391.","journal-title":"Math Biosci Eng"},{"key":"1726_CR14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/lt.26310","volume":"28","author":"S Panchal","year":"2022","unstructured":"Panchal S, Serper M, Bittermann T, et al. Impact of race-adjusted glomerular filtration rate estimation on eligibility for simultaneous liver-kidney transplantation. Liver Transpl. 2022;28:959\u201368.","journal-title":"Liver Transpl"},{"key":"1726_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3389\/fimmu.2017.01519","volume":"8","author":"F Qiu","year":"2017","unstructured":"Qiu F, Liu H, Liang CL, et al. A new immunosuppressive molecule emodin induces both CD4+FoxP3+ and CD8+CD122+ regulatory T cells and suppresses murine allograft rejection. Front Immunol. 2017;8:1519.","journal-title":"Front Immunol"},{"key":"1726_CR16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/tri.12798","volume":"29","author":"N Shuker","year":"2016","unstructured":"Shuker N, Shuker L, van Rosmalen J, et al. A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation. Transpl Int. 2016;29:1158\u201367.","journal-title":"Transpl Int"},{"key":"1726_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/cpt.1618","volume":"107","author":"DRJ Kuypers","year":"2020","unstructured":"Kuypers DRJ. Intrapatient variability of tacrolimus exposure in solid organ transplantation: a novel marker for clinical outcome. Clin Pharmacol Ther. 2020;107:347\u201358.","journal-title":"Clin Pharmacol Ther"},{"key":"1726_CR18","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/ajt.15199","volume":"19","author":"AD Leino","year":"2019","unstructured":"Leino AD, King EC, Jiang W, et al. Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values. Am J Transplant. 2019;19:1410\u201320.","journal-title":"Am J Transplant"},{"issue":"6","key":"1726_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000899","volume":"5","author":"H Mo","year":"2019","unstructured":"Mo H, Kim SY, Min S, et al. Association of intrapatient variability of tacrolimus concentration with early deterioration of chronic histologic lesions in kidney transplantation. Transplant Direct. 2019;5(6): e455.","journal-title":"Transplant Direct"},{"key":"1726_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00467-019-04377-6","volume":"35","author":"S Solomon","year":"2020","unstructured":"Solomon S, Colovai A, Del Rio M, et al. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients. Pediatr Nephrol. 2020;35:261\u201370.","journal-title":"Pediatr Nephrol"},{"key":"1726_CR21","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1111\/ajt.16002","volume":"20","author":"HM Gonzales","year":"2020","unstructured":"Gonzales HM, McGillicuddy JW, Rohan V, et al. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. Am J Transplant. 2020;20:1969\u201383.","journal-title":"Am J Transplant"},{"key":"1726_CR22","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2215\/CJN.16421221","volume":"17","author":"KH Piburn","year":"2022","unstructured":"Piburn KH, Sigurjonsdottir VK, Indridason OS, et al. Patterns in tacrolimus variability and association with de novo donor-specific antibody formation in pediatric kidney transplant recipients. Clin J Am Soc Nephrol. 2022;17:1194\u2013203.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1726_CR23","volume":"14","author":"N Ak\u015fit","year":"2022","unstructured":"Ak\u015fit N, \u00d6zba\u015f A, Ak\u0131nc\u0131 S. Assessment of the effectiveness of patient education and interviews in improving medication adherence of renal transplant recipients. Cureus. 2022;14: e33010.","journal-title":"Cureus"},{"key":"1726_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101723","volume":"75","author":"S Buster","year":"2022","unstructured":"Buster S, Ozsaker E. Locus of control, self-efficacy perception and treatment adherence in kidney transplant patients. Transpl Immunol. 2022;75: 101723.","journal-title":"Transpl Immunol"},{"key":"1726_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/FTD.0000000000000772","volume":"42","author":"SRM Gokoel","year":"2020","unstructured":"Gokoel SRM, Zwart TC, Moes DJAR, et al. No apparent influence of nonadherence on tacrolimus intrapatient variability in stable kidney transplant recipients. Ther Drug Monit. 2020;42:702\u20139.","journal-title":"Ther Drug Monit"},{"key":"1726_CR26","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1038\/s41598-021-84868-5","volume":"11","author":"H Ko","year":"2021","unstructured":"Ko H, Kim HK, Chung C, et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Sci Rep. 2021;11:5397.","journal-title":"Sci Rep"},{"key":"1726_CR27","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.3389\/ti.2023.11141","volume":"36","author":"T Hod","year":"2023","unstructured":"Hod T, Oberman B, Scott N, et al. Predictors and adverse outcomes of acute kidney injury in hospitalized renal transplant recipients. Transpl Int. 2023;36:11141.","journal-title":"Transpl Int"},{"key":"1726_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/FTD.0000000000000955","volume":"44","author":"A Mendoza Rojas","year":"2022","unstructured":"Mendoza Rojas A, Hesselink DA, van Besouw NM, et al. High tacrolimus intrapatient variability and subtherapeutic immunosuppression are associated with adverse kidney transplant outcomes. Ther Drug Monit. 2022;44:369\u201376.","journal-title":"Ther Drug Monit"},{"issue":"12","key":"1726_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746013","volume":"30","author":"Y Park","year":"2021","unstructured":"Park Y, Lee H, Eum SH, et al. Intrapatient variability in tacrolimus trough levels over 2 years affects long-term allograft outcomes of kidney transplantation. Front Immunol. 2021;30(12): 746013.","journal-title":"Front Immunol"},{"key":"1726_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/bcp.14876","volume":"88","author":"S Yin","year":"2022","unstructured":"Yin S, Wang X, Huang Z, et al. Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation. Br J Clin Pharmacol. 2022;88:75\u201383.","journal-title":"Br J Clin Pharmacol"},{"key":"1726_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.973564","volume":"13","author":"B Kostalova","year":"2022","unstructured":"Kostalova B, Mala-Ladova K, Sulkova SD, et al. Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence. Front Pharmacol. 2022;13: 973564.","journal-title":"Front Pharmacol"},{"key":"1726_CR32","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3390\/biomedicines10112860","volume":"10","author":"E Kwiatkowska","year":"2022","unstructured":"Kwiatkowska E, Ciechanowski K, Doma\u0144ski L, et al. Intrapatient variability (IPV) and the blood concentration normalized by the dose (C\/D ratio) of tacrolimus-their correlations and effects on long-term renal allograft function. Biomedicines. 2022;10:2860.","journal-title":"Biomedicines"},{"key":"1726_CR33","doi-asserted-by":"publisher","first-page":"1037566","DOI":"10.3389\/fimmu.2022.1037566","volume":"13","author":"Y Park","year":"2022","unstructured":"Park Y, Lee H, Eum SH, et al. Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation. Front Immunol. 2022;13:1037566.","journal-title":"Front Immunol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01726-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01726-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T13:27:06Z","timestamp":1722259626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01726-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01726-w","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}